Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2013, Article ID 496218, 15 pages
http://dx.doi.org/10.1155/2013/496218
Review Article

Therapeutic Potential of Mesenchymal Stem Cells in Regenerative Medicine

1GIOSTAR/Saviour Hospital, Near Lakhudi Talav, Stadium Road, Navrangpura, Ahmedabad, Gujarat 380014, India
2Global Institute of Stem Cell Therapy and Research, 4370 La Jolla Village Drive San, Diego, CA 92122, USA

Received 21 December 2012; Accepted 25 February 2013

Academic Editor: Rangnath Mishra

Copyright © 2013 Devang M. Patel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Graf, “Differentiation plasticity of hematopoietic cells,” Blood, vol. 99, no. 9, pp. 3089–3101, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. F. M. Watt and B. L. M. Hogan, “Out of eden: stem cells and their niches,” Science, vol. 287, no. 5457, pp. 1427–1430, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. C. D. Porada, E. D. Zanjani, and G. Almeida-Porad, “Adult mesenchymal stem cells: a pluripotent population with multiple applications,” Current stem cell research & therapy, vol. 1, no. 3, pp. 365–369, 2006. View at Google Scholar · View at Scopus
  4. L. da Silva Meirelles, P. C. Chagastelles, and N. B. Nardi, “Mesenchymal stem cells reside in virtually all post-natal organs and tissues,” Journal of Cell Science, vol. 119, no. 11, pp. 2204–2213, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Parekkadan and J. M. Milwid, “Mesenchymal stem cells as therapeutics,” Annual Review of Biomedical Engineering, vol. 12, pp. 87–117, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. J. Friedenstein, U. F. Gorskaja, and N. N. Kulagina, “Fibroblast precursors in normal and irradiated mouse hematopoietic organs,” Experimental Hematology, vol. 4, no. 5, pp. 267–274, 1976. View at Google Scholar · View at Scopus
  7. M. Owen and A. J. Friedenstein, “Stromal stem cells: marrow-derived osteogenic precursors,” Ciba Foundation symposium, vol. 136, pp. 42–60, 1988. View at Google Scholar · View at Scopus
  8. M. Owen, “Marrow stromal stem cells,” Journal of Cell Science, no. 10, pp. 63–76, 1988. View at Google Scholar · View at Scopus
  9. M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. A. I. Caplan, “Mesenchymal stem cells,” Journal of Orthopaedic Research, vol. 9, no. 5, pp. 641–650, 1991. View at Google Scholar · View at Scopus
  11. H. M. Lazarus, S. E. Haynesworth, S. L. Gerson, N. S. Rosenthal, and A. I. Caplan, “Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use,” Bone Marrow Transplantation, vol. 16, no. 4, pp. 557–564, 1995. View at Google Scholar · View at Scopus
  12. H. Motaln, C. Schichor, and T. T. Lah, “Human mesenchymal stem cells and their use in cell-based therapies,” Cancer, vol. 116, no. 11, pp. 2519–2530, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Chamberlain, J. Fox, B. Ashton, and J. Middleton, “Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing,” Stem Cells, vol. 25, no. 11, pp. 2739–2749, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. V. Planat-Benard, J. S. Silvestre, B. Cousin et al., “Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives,” Circulation, vol. 109, no. 5, pp. 656–663, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. V. L. Battula, S. Treml, P. M. Bareiss et al., “Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1,” Haematologica, vol. 94, no. 2, pp. 173–184, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Sivasubramaniyan, D. Lehnen, R. Ghazanfari et al., “Phenotypic and functional heterogeneity of human bone marrow- and amnion-derived MSC subsets,” Annals of the New York Academy of Sciences, vol. 1266, pp. 94–106, 2012. View at Publisher · View at Google Scholar
  17. D. C. Ding, W. C. Shyu, and S. Z. Lin, “Mesenchymal stem cells,” Cell Transplantation, vol. 20, no. 1, pp. 5–14, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. N. S. Hwang, C. Zhang, Y. S. Hwang, and S. Varghese, “Mesenchymal stem cell differentiation and roles in regenerative medicine,” Wiley Interdisciplinary Reviews, vol. 1, no. 1, pp. 97–106, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. C. M. Teven, X. Liu, N. Hu et al., “Epigenetic regulation of mesenchymal stem cells: a focus on osteogenic and adipogenic differentiation,” Stem Cells International, vol. 2011, Article ID 201371, 18 pages, 2011. View at Publisher · View at Google Scholar
  20. Z. L. Deng, K. A. Sharff, N. Tang et al., “Regulation of osteogenic differentiation during skeletal development,” Frontiers in Bioscience, vol. 13, no. 6, pp. 2001–2021, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Baker, G. Zhang, Y. You, and R. S. Tuan, “Caveolin-1 regulates proliferation and osteogenic differentiation of human mesenchymal stem cells,” Journal of Cellular Biochemistry, vol. 113, no. 12, pp. 3773–3787, 2012. View at Publisher · View at Google Scholar
  22. D. J. Xu, Y. Z. Zhao, J. Wang, J. W. He, Y. G. Weng, and J. Y. Luo, “Smads p38 and ERK1/2 are involved in BMP9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells,” BMB Reports, vol. 45, no. 4, pp. 247–252, 2012. View at Publisher · View at Google Scholar
  23. H. Zheng, Z. Guo, Q. Ma, H. Jia, and G. Dang, “Cbfa1/osf2 transduced bone marrow stromal cells facilitate bone formation in vitro and in vivo,” Calcified Tissue International, vol. 74, no. 2, pp. 194–203, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Gaur, C. J. Lengner, H. Hovhannisyan et al., “Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression,” Journal of Biological Chemistry, vol. 280, no. 39, pp. 33132–33140, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. J. J. Alm, T. J. Heino, T. A. Hentunen, H. K. Vaananen, and H. T. Aro, “Transient 100 nM dexamethasone treatment reduces inter- and intraindividual variations in osteoblastic differentiation of bone marrow-derived human mesenchymal stem cells,” Tissue Engineering C, vol. 18, no. 9, pp. 658–666, 2012. View at Publisher · View at Google Scholar
  26. K. Cameron, P. Travers, C. Chander, T. Buckland, C. Campion, and B. Noble, “Directed osteogenic differentiation of human mesenchymal stem/precursor cells on silicate substituted calcium phosphate,” Journal of Biomedical Materials Research A, vol. 101, no. 1, pp. 13–22, 2013. View at Google Scholar
  27. Z. Tang, D. Shi, B. Jia et al., “Exchange protein activated by cyclic adenosine monophosphate regulates the switch between adipogenesis and osteogenesis of human mesenchymal stem cells through increasing the activation of phosphatidylinositol 3-kinase,” The International Journal of Biochemistry & Cell Biology, vol. 44, no. 7, pp. 1106–1120, 2012. View at Publisher · View at Google Scholar
  28. C. Y. C. Huang, K. L. Hagar, L. E. Frost, Y. Sun, and H. S. Cheung, “Effects of cyclic compressive loading on chondrogenesis of rabbit bone-marrow derived mesenchymal stem cells,” Stem Cells, vol. 22, no. 3, pp. 313–323, 2004. View at Google Scholar · View at Scopus
  29. S. Paik, H. S. Jung, S. Lee, D. S. Yoon, M. S. Park, and J. W. Lee, “miR-449a regulates the chondrogenesis of human mesenchymal stem cells through direct targeting of lymphoid enhancer-binding factor-1,” Stem Cells and Development, vol. 21, no. 18, pp. 3298–3308, 2012. View at Publisher · View at Google Scholar
  30. T. F. Day, X. Guo, L. Garrett-Beal, and Y. Yang, “Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis,” Developmental Cell, vol. 8, no. 5, pp. 739–750, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Cheng, C. Yang, N. Weber, H. T. Kim, and A. C. Kuo, “Fibroblast growth factor 2 enhances the kinetics of mesenchymal stem cell chondrogenesis,” Biochemical and Biophysical Research Communications, vol. 426, no. 4, pp. 544–550, 2012. View at Publisher · View at Google Scholar
  32. J. Yanjie, S. Jiping, Z. Yan, Z. Xiaofeng, Z. Boai, and L. Yajun, “Effects of Notch-1 signalling pathway on differentiation of marrow mesenchymal stem cells into neurons in vitro,” NeuroReport, vol. 18, no. 14, pp. 1443–1447, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Wang, Q. Kan, Y. Sun et al., “Caveolin-1 regulates neural differentiation of rat bone mesenchymal stem cells into neurons by modulating notch signaling,” International Journal of Developmental Neuroscience, vol. 31, no. 1, pp. 30–35, 2012. View at Publisher · View at Google Scholar
  34. K. D. Lee, T. K. C. Kuo, J. Whang-Peng et al., “In vitro hepatic differentiation of human mesenchymal stem cells,” Hepatology, vol. 40, no. 6, pp. 1275–1284, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. L. B. Chen, X. B. Jiang, and L. Yang, “Differentiation of rat marrow mesenchymal stem cells into pancreatic islet β-cells,” World Journal of Gastroenterology, vol. 10, no. 20, pp. 3016–3020, 2004. View at Google Scholar · View at Scopus
  36. D. R. Bhandari, K. W. Seo, K. H. Roh, J. W. Jung, S. K. Kang, and K. S. Kang, “REX-1 expression and p38 MAPK activation status can determine proliferation/differentiation fates in human mesenchymal stem Cells,” PLoS ONE, vol. 5, no. 5, Article ID e10493, 2010. View at Google Scholar · View at Scopus
  37. V. Chandra, S. G, S. Phadnis, P. D. Nair, and R. R. Bhonde, “Generation of pancreatic hormone-expressing islet-like cell aggregates from murine adipose tissue-derived stem cells,” Stem Cells, vol. 27, no. 8, pp. 1941–1953, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Ray, A. De, J. J. Min, R. Y. Tsien, and S. S. Gambhir, “Imaging tri-fusion multimodality reporter gene expression in living subjects,” Cancer Research, vol. 64, no. 4, pp. 1323–1330, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. T. R. Brazelton and H. M. Blau, “Optimizing techniques for tracking transplanted stem cells in vivo,” Stem Cells, vol. 23, no. 9, pp. 1251–1265, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. W. R. Otto and N. A. Wright, “Mesenchymal stem cells: from experiment to clinic,” Fibrogenesis & Tissue Repair, vol. 4, p. 20, 2011. View at Publisher · View at Google Scholar
  41. F. Granero-Molto, J. A. Weis, L. Longobardi, and A. Spagnoli, “Role of mesenchymal stem cells in regenerative medicine: application to bone and cartilage repair,” Expert Opinion on Biological Therapy, vol. 8, no. 3, pp. 255–268, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. K. I. Hiasa, M. Ishibashi, K. Ohtani et al., “Gene transfer of stromal cell-derived factor-1α enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization,” Circulation, vol. 109, no. 20, pp. 2454–2461, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Ma, J. Ge, S. Zhang et al., “Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction,” Basic Research in Cardiology, vol. 100, no. 3, pp. 217–223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. J. E. Ip, Y. Wu, J. Huang, L. Zhang, R. E. Pratt, and V. J. Dzau, “Mesenchymal stem cells use integrin β1 not CXC chemokine receptor 4 for myocardial migration and engraftment,” Molecular Biology of the Cell, vol. 18, no. 8, pp. 2873–2882, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. X. Hou, X. Wu, J. Ma, X. Lv, and X. Jin, “Erythropoietin augments the efficacy of therapeutic angiogenesis induced by allogenic bone marrow stromal cells in a rat model of limb ischemia,” Molecular Biology Reports, vol. 37, no. 3, pp. 1467–1475, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. L. Badri and V. N. Lama, “Lysophosphatidic acid induces migration of human lung-resident mesenchymal stem cells through the β-catenin pathway,” Stem Cells, vol. 30, no. 9, pp. 2010–2019, 2012. View at Publisher · View at Google Scholar
  47. D. O. Freytes, J. W. Kang, I. Marcos-Campos, and G. Vunjak-Novakovic, “Macrophages modulate the viability and growth of human mesenchymal stem cells,” Journal of Cellular Biochemistry, vol. 114, no. 1, pp. 220–229, 2013. View at Publisher · View at Google Scholar
  48. B. Rüster, S. Göttig, R. J. Ludwig et al., “Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells,” Blood, vol. 108, no. 12, pp. 3938–3944, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Mirza, J. M. Hyvelin, G. Y. Rochefort et al., “Undifferentiated mesenchymal stem cells seeded on a vascular prosthesis contribute to the restoration of a physiologic vascular wall,” Journal of Vascular Surgery, vol. 47, no. 6, pp. 1313–1321, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. Z. Sheng, X. Fu, S. Cai et al., “Regeneration of functional sweat gland-like structures by transplanted differentiated bone marrow mesenchymal stem cells,” Wound Repair and Regeneration, vol. 17, no. 3, pp. 427–435, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. C. E. P. Aronin and R. S. Tuan, “Therapeutic potential of the immunomodulatory activities of adult mesenchymal stem cells,” Birth Defects Research C, vol. 90, no. 1, pp. 67–74, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. Y. Li, J. Chen, X. G. Chen et al., “Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery,” Neurology, vol. 59, no. 4, pp. 514–523, 2002. View at Google Scholar · View at Scopus
  53. A. T. Askari, S. Unzek, Z. B. Popovic et al., “Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy,” The Lancet, vol. 362, no. 9385, pp. 697–703, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. M. D. Nicola, C. Carlo-Stella, M. Magni et al., “Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli,” Blood, vol. 99, no. 10, pp. 3838–3843, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Bartholomew, C. Sturgeon, M. Siatskas et al., “Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo,” Experimental Hematology, vol. 30, no. 1, pp. 42–48, 2002. View at Publisher · View at Google Scholar · View at Scopus
  56. F. Djouad, P. Plence, C. Bony et al., “Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals,” Blood, vol. 102, no. 10, pp. 3837–3844, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. F. Djouad, L. M. Charbonnier, C. Bouffi et al., “Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism,” Stem Cells, vol. 25, no. 8, pp. 2025–2032, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Glennie, I. Soeiro, P. J. Dyson, E. W. F. Lam, and F. Dazzi, “Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells,” Blood, vol. 105, no. 7, pp. 2821–2827, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. P. A. Sotiropoulou, S. A. Perez, A. D. Gritzapis, C. N. Baxevanis, and M. Papamichail, “Interactions between human mesenchymal stem cells and natural killer cells,” Stem Cells, vol. 24, no. 1, pp. 74–85, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. G. M. Spaggiari, A. Capobianco, S. Becchetti, M. C. Mingari, and L. Moretta, “Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation,” Blood, vol. 107, no. 4, pp. 1484–1490, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. K. Le Blanc, I. Rasmusson, B. Sundberg et al., “Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells,” The Lancet, vol. 363, no. 9419, pp. 1439–1441, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. Z. H. Zheng, X. Y. Li, J. Ding, J. F. Jia, and P. Zhu, “Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis,” Rheumatology, vol. 47, no. 1, pp. 22–30, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. F. Dazzi and M. Krampera, “Mesenchymal stem cells and autoimmune diseases,” Best Practice and Research, vol. 24, no. 1, pp. 49–57, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. T. Yi and S. U. Song, “Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications,” Archives of Pharmacal Research, vol. 35, no. 2, pp. 213–221, 2012. View at Publisher · View at Google Scholar
  65. Y. O. Joo, K. K. Mee, S. S. Mi et al., “The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury,” Stem Cells, vol. 26, no. 4, pp. 1047–1055, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. M. E. Groh, B. Maitra, E. Szekely, and O. N. Koç, “Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells,” Experimental Hematology, vol. 33, no. 8, pp. 928–934, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Jones, N. Horwood, A. Cope, and F. Dazzi, “The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells,” Journal of Immunology, vol. 179, no. 5, pp. 2824–2831, 2007. View at Google Scholar · View at Scopus
  68. M. P. De Miguel, S. Fuentes-Julian, A. Blazquez-Martinez et al., “Immunosuppressive properties of mesenchymal stem cells: advances and applications,” Current Molecular Medicine, vol. 12, no. 5, pp. 574–591, 2012. View at Publisher · View at Google Scholar
  69. W. Li, G. Ren, Y. Huang et al., “Mesenchymal stem cells: a double-edged sword in regulating immune responses,” Cell Death and Differentiation, vol. 19, pp. 1505–1513, 2012. View at Publisher · View at Google Scholar
  70. P. K. Mishra, S. R. Singh, I. G. Joshua, and S. C. Tyagi, “Stem cells as a therapeutic target for diabetes,” Frontiers in Bioscience, vol. 15, no. 2, pp. 461–477, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. V. Volarevic, N. Arsenijevic, M. L. Lukic, and M. Stojkovic, “Concise review: mesenchymal stem cell treatment of the complications of diabetes mellitus,” Stem Cells, vol. 29, no. 1, pp. 5–10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. Y. Sun, L. Chen, X. G. Hou et al., “Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro,” Chinese Medical Journal, vol. 120, no. 9, pp. 771–776, 2007. View at Google Scholar · View at Scopus
  73. K. C. Chao, K. F. Chao, Y. S. Fu, and S. H. Liu, “Islet-like clusters derived from mesenchymal stem cells in Wharton's jelly of the human umbilical cord for transplantation to control type 1 diabetes,” PLoS ONE, vol. 3, no. 1, Article ID e1451, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. J. A. Cancelas and D. A. Williams, “Stem cell mobilization by β2-agonists,” Nature Medicine, vol. 12, no. 3, pp. 278–279, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. Q. S. Guo, M. Y. Zhu, L. Wang et al., “Combined transfection of the three transcriptional factors, PDX-1, NeuroD1, and MafA, causes differentiation of bone marrow mesenchymal stem cells into insulin-producing cells,” Experimental Diabetes Research, vol. 2012, Article ID 672013, 10 pages, 2012. View at Publisher · View at Google Scholar
  76. H. T. Li, F. X. Jiang, P. Shi et al., “In vitro reprogramming of rat bone marrow-derived mesenchymal stem cells into insulin-producing cells by genetically manipulating negative and positive regulators,” Biochemical and Biophysical Research Communications, vol. 420, no. 4, pp. 793–798, 2012. View at Publisher · View at Google Scholar
  77. K. Timper, D. Seboek, M. Eberhardt et al., “Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells,” Biochemical and Biophysical Research Communications, vol. 341, no. 4, pp. 1135–1140, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. F. Ezquer, M. Ezquer, D. Contador, M. Ricca, V. Simon, and P. Conget, “The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment,” Stem Cells, vol. 30, no. 8, pp. 1664–1674, 2012. View at Publisher · View at Google Scholar
  79. J. H. Ho, T. C. Tseng, W. H. Ma et al., “Multiple intravenous transplantations of mesenchymal stem cells effectively restore long-term blood glucose homeostasis by hepatic engraftment and beta-cell differentiation in streptozocin-induced diabetic mice,” Cell Transplantation, vol. 21, no. 1, pp. 217–234, 2012. View at Publisher · View at Google Scholar
  80. Y. Si, Y. Zhao, H. Hao et al., “Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity,” Diabetes, vol. 61, no. 6, pp. 1616–1625, 2012. View at Publisher · View at Google Scholar
  81. R. Jiang, Z. Han, G. Zhuo et al., “Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study,” Frontiers of Medicine, vol. 5, no. 1, pp. 94–100, 2011. View at Publisher · View at Google Scholar
  82. M. Yu, W. Zhou, Y. Song et al., “Development of mesenchymal stem cell-implant complexes by cultured cells sheet enhances osseointegration in type 2 diabetic rat model,” Bone, vol. 49, no. 3, pp. 387–394, 2011. View at Publisher · View at Google Scholar · View at Scopus
  83. A. Bhansali, V. Upreti, N. Khandelwal et al., “Efficacy of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus,” Stem Cells and Development, vol. 18, no. 10, pp. 1407–1415, 2009. View at Publisher · View at Google Scholar · View at Scopus
  84. T. M. Camp, S. C. Tyagi, R. M. Senior, M. R. Hayden, and S. C. Tyagi, “Gelatinase B(MMP-9) an apoptotic factor in diabetic transgenic mice,” Diabetologia, vol. 46, no. 10, pp. 1438–1445, 2003. View at Publisher · View at Google Scholar · View at Scopus
  85. Y. S. Yoon, S. Uchida, O. Masuo et al., “Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor,” Circulation, vol. 111, no. 16, pp. 2073–2085, 2005. View at Publisher · View at Google Scholar · View at Scopus
  86. N. Zhang, J. Li, R. Luo, J. Jiang, and J. A. Wang, “Bone marrow mesenchymal stem cells induce angiogenesis and attenuate the remodeling of diabetic cardiomyopathy,” Experimental and Clinical Endocrinology and Diabetes, vol. 116, no. 2, pp. 104–111, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. M. B. Herrera, B. Bussolati, S. Bruno, V. Fonsato, G. M. Romanazzi, and G. Camussi, “Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury,” International journal of molecular medicine, vol. 14, no. 6, pp. 1035–1041, 2004. View at Google Scholar · View at Scopus
  88. F. Ezquer, M. Ezquer, V. Simon et al., “Endovenous administration of bone marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice,” Biology of Blood and Marrow Transplantation, vol. 15, no. 11, pp. 1354–1365, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. R. H. Lee, M. J. Seo, R. L. Reger et al., “Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 46, pp. 17438–17443, 2006. View at Publisher · View at Google Scholar · View at Scopus
  90. T. Shibata, K. Naruse, H. Kamiya et al., “Transplantation of bone marrow-derived mesenchymal stem cells improves diabetic polyneuropathy in rats,” Diabetes, vol. 57, no. 11, pp. 3099–3107, 2008. View at Publisher · View at Google Scholar · View at Scopus
  91. D. S. Kwon, X. Gao, Y. B. Liu et al., “Treatment with bone marrow-derived stromal cells accelerates wound healing in diabetic rats,” International Wound Journal, vol. 5, no. 3, pp. 453–463, 2008. View at Publisher · View at Google Scholar · View at Scopus
  92. A. R. Williams and J. M. Hare, “Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease,” Circulation Research, vol. 109, pp. 923–940, 2011. View at Publisher · View at Google Scholar
  93. T. J. Cashman, V. Gouon-Evans, and K. D. Costa, “Mesenchymal stem cells for cardiac therapy: practical challenges and potential mechanisms,” Stem Cell Reviews. In press.
  94. J. G. Shake, P. J. Gruber, W. A. Baumgartner et al., “Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects,” Annals of Thoracic Surgery, vol. 73, no. 6, pp. 1919–1926, 2002. View at Publisher · View at Google Scholar · View at Scopus
  95. C. Toma, M. F. Pittenger, K. S. Cahill, B. J. Byrne, and P. D. Kessler, “Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart,” Circulation, vol. 105, no. 1, pp. 93–98, 2002. View at Publisher · View at Google Scholar · View at Scopus
  96. H. C. Quevedo, K. E. Hatzistergos, B. N. Oskouei et al., “Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 33, pp. 14022–14027, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. R. R. Makkar, M. J. Price, M. Lill et al., “Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction,” Journal of Cardiovascular Pharmacology and Therapeutics, vol. 10, no. 4, pp. 225–233, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. G. V. Silva, S. Litovsky, J. A. R. Assad et al., “Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model,” Circulation, vol. 111, no. 2, pp. 150–156, 2005. View at Publisher · View at Google Scholar · View at Scopus
  99. Y. J. Yang, H. Y. Qian, J. Huang et al., “Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 12, pp. 2076–2082, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. J. A. Dixon, R. C. Gorman, R. E. Stroud et al., “Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction,” Circulation, vol. 120, no. 1, pp. S220–S229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  101. S. L. Chen, W. W. Fang, F. Ye et al., “Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction,” American Journal of Cardiology, vol. 94, no. 1, pp. 92–95, 2004. View at Publisher · View at Google Scholar · View at Scopus
  102. J. M. Hare, J. H. Traverse, T. D. Henry et al., “A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction,” Journal of the American College of Cardiology, vol. 54, no. 24, pp. 2277–2286, 2009. View at Publisher · View at Google Scholar · View at Scopus
  103. A. R. Williams, B. Trachtenberg, D. L. Velazquez et al., “Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling,” Circulation Research, vol. 108, pp. 792–796, 2011. View at Publisher · View at Google Scholar
  104. J. C. Chachques, J. C. Trainini, N. Lago et al., “Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM clinical trial): one year follow-up,” Cell Transplantation, vol. 16, no. 9, pp. 927–934, 2007. View at Publisher · View at Google Scholar · View at Scopus
  105. J. C. Chachques, J. C. Trainini, N. Lago, M. Cortes-Morichetti, O. Schussler, and A. Carpentier, “Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM trial): clinical feasibility study,” Annals of Thoracic Surgery, vol. 85, no. 3, pp. 901–908, 2008. View at Publisher · View at Google Scholar · View at Scopus
  106. A. Shabbir, D. Zisa, H. Lin et al., “Activation of host tissue trophic factors through JAK-STAT3 signaling: a mechanism of mesenchymal stem cell-mediated cardiac repair,” American Journal of Physiology, vol. 299, no. 5, pp. H1428–H1438, 2010. View at Publisher · View at Google Scholar · View at Scopus
  107. J. DeSantiago, D. J. Bare, I. Semenov et al., “Excitation-contraction coupling in ventricular myocytes is enhanced by paracrine signaling from mesenchymal stem cells,” Journal of Molecular and Cellular Cardiology, vol. 52, no. 6, pp. 1249–1256, 2012. View at Publisher · View at Google Scholar
  108. P. Stock, S. Brückner, S. Ebensing, M. Hempel, M. M. Dollinger, and B. Christ, “The generation of hepatocytes from mesenchymal stem cells and engraftment into murine liver,” Nature Protocols, vol. 5, no. 4, pp. 617–627, 2010. View at Publisher · View at Google Scholar · View at Scopus
  109. Y. Sato, H. Araki, J. Kato et al., “Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion,” Blood, vol. 106, no. 2, pp. 756–763, 2005. View at Publisher · View at Google Scholar · View at Scopus
  110. Y. J. Chang, J. W. Liu, P. C. Lin et al., “Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis,” Life Sciences, vol. 85, no. 13-14, pp. 517–525, 2009. View at Publisher · View at Google Scholar · View at Scopus
  111. S. Hwang, H. N. Hong, H. S. Kim et al., “Hepatogenic differentiation of mesenchymal stem cells in a rat model of thioacetamide-induced liver cirrhosis,” Cell Biology International, vol. 36, no. 3, pp. 279–288, 2011. View at Publisher · View at Google Scholar
  112. D. C. Zhao, J. X. Lei, R. Chen et al., “Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats,” World Journal of Gastroenterology, vol. 11, no. 22, pp. 3431–3440, 2005. View at Google Scholar · View at Scopus
  113. M. T. Abdel Aziz, H. M. Atta, S. Mahfouz et al., “Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis,” Clinical Biochemistry, vol. 40, no. 12, pp. 893–899, 2007. View at Publisher · View at Google Scholar · View at Scopus
  114. P. C. Tsai, T. W. Fu, Y. M. A. Chen et al., “The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis,” Liver Transplantation, vol. 15, no. 5, pp. 484–495, 2009. View at Publisher · View at Google Scholar · View at Scopus
  115. T. K. Kuo, S. P. Hung, C. H. Chuang et al., “Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells,” Gastroenterology, vol. 134, no. 7, pp. 2111–2121.e3, 2008. View at Publisher · View at Google Scholar · View at Scopus
  116. P. Burra, D. Arcidiacono, D. Bizzaro et al., “Systemic administration of a novel human umbilical cord mesenchymal stem cells population accelerates the resolution of acute liver injury,” BMC Gastroenterology, vol. 12, p. 88, 2012. View at Publisher · View at Google Scholar
  117. H. Xu, H. Qian, W. Zhu et al., “Mesenchymal stem cells relieve fibrosis of Schistosoma japonicum-induced mouse liver injury,” Experimental Biology and Medicine, vol. 237, no. 5, pp. 585–592, 2012. View at Publisher · View at Google Scholar
  118. K. A. Cho, S. Y. Woo, J. Y. Seoh, H. S. Han, and K. H. Ryu, “Mesenchymal stem cells restore CCl4-induced liver injury by an antioxidative process,” Cell Biology International, vol. 36, pp. 1267–1274, 2012. View at Publisher · View at Google Scholar
  119. V. Aldridge, A. Garg, N. Davies et al., “Human mesenchymal stem cells are recruited to injured liver in a β1-integrin and CD44 dependent manner,” Hepatology, vol. 56, pp. 1063–1073, 2012. View at Google Scholar
  120. H. Cao, J. Yang, J. Yu et al., “Therapeutic potential of transplanted placental mesenchymal stem cells in treating Chinese miniature pigs with acute liver failure,” BMC Medicine, vol. 10, p. 56, 2012. View at Publisher · View at Google Scholar
  121. W. Zhao, J. J. Li, D. Y. Cao et al., “Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis,” World Journal of Gastroenterology, vol. 18, pp. 1048–1058, 2012. View at Publisher · View at Google Scholar
  122. M. El Ansary, I. Abdel-Aziz, S. Mogawer et al., “Phase II Trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis,” Stem Cell Rreviews, vol. 8, no. 3, pp. 972–981, 2012. View at Publisher · View at Google Scholar
  123. P. Kharaziha, P. M. Hellström, B. Noorinayer et al., “Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial,” European Journal of Gastroenterology and Hepatology, vol. 21, no. 10, pp. 1199–1205, 2009. View at Publisher · View at Google Scholar · View at Scopus
  124. M. Mohamadnejad, K. Alimoghaddam, M. Mohyeddin-Bonab et al., “Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis,” Archives of Iranian Medicine, vol. 10, no. 4, pp. 459–466, 2007. View at Google Scholar · View at Scopus
  125. Z. Zhang, H. Lin, M. Shi et al., “Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients,” Journal of Gastroenterology and Hepatology, vol. 27, no. supplement 2, pp. 112–120, 2012. View at Publisher · View at Google Scholar
  126. L. Peng, D. Y. Xie, B. L. Lin et al., “Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes,” Hepatology, vol. 54, no. 3, pp. 820–828, 2011. View at Publisher · View at Google Scholar
  127. G. Ali, S. Mohsin, M. Khan et al., “Nitric oxide augments mesenchymal stem cell ability to repair liver fibrosis,” Journal of Translational Medicine, vol. 10, p. 75, 2012. View at Publisher · View at Google Scholar
  128. J. W. Cho, C. Y. Lee, and Y. Ko, “Therapeutic potential of mesenchymal stem cells overexpressing human forkhead box A2 gene in the regeneration of damaged liver tissues,” Journal of Gastroenterology and Hepatology, vol. 27, no. 8, pp. 1362–1370, 2012. View at Publisher · View at Google Scholar
  129. C. Alfarano, C. Roubeix, R. Chaaya et al., “Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats,” Cell transplantation, vol. 21, no. 9, pp. 2009–2019, 2012. View at Publisher · View at Google Scholar
  130. M. Morigi, B. Imberti, C. Zoja et al., “Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure,” Journal of the American Society of Nephrology, vol. 15, no. 7, pp. 1794–1804, 2004. View at Publisher · View at Google Scholar · View at Scopus
  131. M. B. Herrera, B. Bussolati, S. Bruno et al., “Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury,” Kidney International, vol. 72, no. 4, pp. 430–441, 2007. View at Publisher · View at Google Scholar · View at Scopus
  132. C. Zoja, P. B. Garcia, C. Rota et al., “Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathy,” American Journal of Physiology, vol. 303, no. 9, pp. F1370–F1381, 2012. View at Publisher · View at Google Scholar
  133. T. H. Yen, M. R. Alison, H. T. Cook et al., “The cellular origin and proliferative status of regenerating renal parenchyma after mercuric chloride damage and erythropoietin treatment,” Cell Proliferation, vol. 40, no. 2, pp. 143–156, 2007. View at Publisher · View at Google Scholar · View at Scopus
  134. A. F. Wise and S. D. Ricardo, “Mesenchymal stem cells in kidney inflammation and repair,” Nephrology, vol. 17, no. 1, 2012. View at Publisher · View at Google Scholar
  135. B. D. Humphreys and J. V. Bonventre, “Mesenchymal stem cells in acute kidney injury,” Annual Review of Medicine, vol. 59, pp. 311–325, 2008. View at Publisher · View at Google Scholar · View at Scopus
  136. H. L. Tang, Z. G. Wang, Q. Li et al., “Targeted delivery of bone mesenchymal stem cells by ultrasound destruction of microbubbles promotes kidney recovery in acute kidney injury,” Ultrasound in Medicine and Biology, vol. 38, no. 4, pp. 661–669, 2012. View at Publisher · View at Google Scholar
  137. M. El Ansary, G. Saadi, and S. M. Abd El-Hamid, “Mesenchymal stem cells are a rescue approach for recovery of deteriorating kidney function,” Nephrology, vol. 17, no. 7, pp. 650–657, 2012. View at Publisher · View at Google Scholar
  138. M. Griffin, S. A. Iqbal, and A. Bayat, “Exploring the application of mesenchymal stem cells in bone repair and regeneration,” Journal of Bone and Joint Surgery B, vol. 93, no. 4, pp. 427–434, 2011. View at Publisher · View at Google Scholar · View at Scopus
  139. S. P. Bruder, A. A. Kurth, M. Shea, W. C. Hayes, N. Jaiswal, and S. Kadiyala, “Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells,” Journal of Orthopaedic Research, vol. 16, no. 2, pp. 155–162, 1998. View at Publisher · View at Google Scholar · View at Scopus
  140. R. Quarto, M. Mastrogiacomo, R. Cancedda et al., “Repair of large bone defects with the use of autologous bone marrow stromal cells,” The New England Journal of Medicine, vol. 344, no. 5, pp. 385–386, 2001. View at Publisher · View at Google Scholar · View at Scopus
  141. M. Marcacci, E. Kon, V. Moukhachev et al., “Stem cells associated with macroporous bioceramics for long bone repair: 6- To 7-year outcome of a pilot clinical study,” Tissue Engineering, vol. 13, no. 5, pp. 947–955, 2007. View at Publisher · View at Google Scholar · View at Scopus
  142. H. Kitoh, T. Kitakoji, H. Tsuchiya et al., “Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis—a preliminary result of three cases,” Bone, vol. 35, no. 4, pp. 892–898, 2004. View at Publisher · View at Google Scholar · View at Scopus
  143. K. Kawate, H. Yajima, H. Ohgushi et al., “Tissue-engineered approach for the treatment of steroid-induced osteonecrosis of the femoral head: transplantation of autologous mesenchymal stem cells cultured with β-tricalcium phosphate ceramics and free vascularized fibula,” Artificial Organs, vol. 30, no. 12, pp. 960–962, 2006. View at Publisher · View at Google Scholar · View at Scopus
  144. Y. Gan, K. Dai, P. Zhang, T. Tang, Z. Zhu, and J. Lu, “The clinical use of enriched bone marrow stem cells combined with porous β-tricalcium phosphate in posterior spinal fusion,” Biomaterials, vol. 29, no. 29, pp. 3973–3982, 2008. View at Publisher · View at Google Scholar · View at Scopus
  145. T. Kitaori, H. Ito, E. M. Schwarz et al., “Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model,” Arthritis and Rheumatism, vol. 60, no. 3, pp. 813–823, 2009. View at Publisher · View at Google Scholar · View at Scopus
  146. P. Hernigou, A. Poignard, F. Beaujean, and H. Rouard, “Percutaneous autologous bone-marrow grafting for nonunions: influence of the number and concentration of progenitor cells,” Journal of Bone and Joint Surgery A, vol. 87, no. 7, pp. 1430–1437, 2005. View at Publisher · View at Google Scholar · View at Scopus
  147. R. F. Pereira, M. D. O'Hara, A. V. Laptev et al., “Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 3, pp. 1142–1147, 1998. View at Publisher · View at Google Scholar · View at Scopus
  148. C. Panaroni, R. Gioia, A. Lupi et al., “In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfecta,” Blood, vol. 114, no. 2, pp. 459–468, 2009. View at Publisher · View at Google Scholar · View at Scopus
  149. E. M. Horwitz, D. J. Prockop, L. A. Fitzpatrick et al., “Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta,” Nature Medicine, vol. 5, no. 3, pp. 309–313, 1999. View at Publisher · View at Google Scholar · View at Scopus
  150. E. M. Horwitz, D. J. Prockop, P. L. Gordon et al., “Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta,” Blood, vol. 97, no. 5, pp. 1227–1231, 2001. View at Publisher · View at Google Scholar · View at Scopus
  151. E. M. Horwitz, P. L. Gordon, W. K. K. Koo et al., “Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 13, pp. 8932–8937, 2002. View at Publisher · View at Google Scholar · View at Scopus
  152. K. Le Blanc, C. Götherström, O. Ringdén et al., “Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta,” Transplantation, vol. 79, no. 11, pp. 1607–1614, 2005. View at Publisher · View at Google Scholar · View at Scopus
  153. M. P. Whyte, J. Kurtzberg, W. H. McAlister et al., “Marrow cell transplantation for infantile hypophosphatasia,” Journal of Bone and Mineral Research, vol. 18, no. 4, pp. 624–636, 2003. View at Google Scholar · View at Scopus
  154. A. Uccelli, L. Moretta, and V. Pistoia, “Mesenchymal stem cells in health and disease,” Nature Reviews Immunology, vol. 8, no. 9, pp. 726–736, 2008. View at Publisher · View at Google Scholar · View at Scopus
  155. K. Le Blanc, F. Frassoni, L. Ball et al., “Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study,” The Lancet, vol. 371, no. 9624, pp. 1579–1586, 2008. View at Publisher · View at Google Scholar · View at Scopus
  156. P. Kebriaei, L. Isola, E. Bahceci et al., “Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease,” Biology of Blood and Marrow Transplantation, vol. 15, no. 7, pp. 804–811, 2009. View at Publisher · View at Google Scholar · View at Scopus
  157. M. Duijvestein, A. C. Vos, H. Roelofs et al., “Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study,” Gut, vol. 59, no. 12, pp. 1662–1669, 2010. View at Publisher · View at Google Scholar
  158. J. Dalal, K. Gandy, and J. Domen, “Role of mesenchymal stem cell therapy in Crohn's disease,” Pediatric Research, vol. 71, pp. 445–451, 2012. View at Publisher · View at Google Scholar
  159. L. Bai, D. P. Lennon, V. Eaton et al., “Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis,” Glia, vol. 57, no. 11, pp. 1192–1203, 2009. View at Publisher · View at Google Scholar · View at Scopus
  160. G. Constantin, S. Marconi, B. Rossi et al., “Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis,” Stem Cells, vol. 27, no. 10, pp. 2624–2635, 2009. View at Publisher · View at Google Scholar · View at Scopus
  161. E. Gerdoni, B. Gallo, S. Casazza et al., “Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis,” Annals of Neurology, vol. 61, no. 3, pp. 219–227, 2007. View at Publisher · View at Google Scholar · View at Scopus
  162. D. Gordon, G. Pavlovska, C. P. Glover, J. B. Uney, D. Wraith, and N. J. Scolding, “Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration,” Neuroscience Letters, vol. 448, no. 1, pp. 71–73, 2008. View at Publisher · View at Google Scholar · View at Scopus
  163. M. Rafei, P. M. Campeau, A. Aguilar-Mahecha et al., “Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner,” Journal of Immunology, vol. 182, no. 10, pp. 5994–6002, 2009. View at Publisher · View at Google Scholar · View at Scopus
  164. J. Zhang, Y. Li, J. Chen et al., “Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice,” Experimental Neurology, vol. 195, no. 1, pp. 16–26, 2005. View at Publisher · View at Google Scholar · View at Scopus
  165. I. Kassis, N. Grigoriadis, B. Gowda-Kurkalli et al., “Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis,” Archives of Neurology, vol. 65, no. 6, pp. 753–761, 2008. View at Publisher · View at Google Scholar · View at Scopus
  166. J. Zhang, Y. Li, M. Lu et al., “Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice,” Journal of Neuroscience Research, vol. 84, no. 3, pp. 587–595, 2006. View at Publisher · View at Google Scholar · View at Scopus
  167. M. M. Bonab, M. A. Sahraian, A. Aghsaie et al., “Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study,” Current stem cell research & therapy, vol. 7, no. 6, pp. 407–414, 2012. View at Google Scholar
  168. B. Yamout, R. Hourani, H. Salti et al., “Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study,” Journal of Neuroimmunology, vol. 227, no. 1-2, pp. 185–189, 2010. View at Publisher · View at Google Scholar · View at Scopus
  169. L. P. Rowland and N. A. Shneider, “Amyotrophic lateral sclerosis,” The New England Journal of Medicine, vol. 344, no. 22, pp. 1688–1700, 2001. View at Publisher · View at Google Scholar · View at Scopus
  170. D. Karussis, I. Kassis, B. G. S. Kurkalli, and S. Slavin, “Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases,” Journal of the Neurological Sciences, vol. 265, no. 1-2, pp. 131–135, 2008. View at Publisher · View at Google Scholar · View at Scopus
  171. M. S. Freedman, A. Bar-Or, H. L. Atkins et al., “The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the international MSCT study group,” Multiple Sclerosis, vol. 16, no. 4, pp. 503–510, 2010. View at Publisher · View at Google Scholar · View at Scopus
  172. L. Mazzini, I. Ferrero, V. Luparello et al., “Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a phase I clinical trial,” Experimental Neurology, vol. 223, no. 1, pp. 229–237, 2010. View at Publisher · View at Google Scholar · View at Scopus
  173. A. Augello, R. Tasso, S. M. Negrini, R. Cancedda, and G. Pennesi, “Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis,” Arthritis and Rheumatism, vol. 56, no. 4, pp. 1175–1186, 2007. View at Publisher · View at Google Scholar · View at Scopus
  174. F. Djouad, V. Fritz, F. Apparailly et al., “Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor α in collagen-induced arthritis,” Arthritis and Rheumatism, vol. 52, no. 5, pp. 1595–1603, 2005. View at Publisher · View at Google Scholar · View at Scopus
  175. L. J. Dai, M. R. Moniri, Z. R. Zeng, J. X. Zhou, J. Rayat, and G. L. Warnock, “Potential implications of mesenchymal stem cells in cancer therapy,” Cancer Letters, vol. 305, no. 1, pp. 8–20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  176. Q. Bao, Y. Zhao, H. Niess et al., “Mesenchymal stem cell-based tumor-targeted gene therapy in gastrointestinal cancer,” Stem Cells and Development, vol. 21, no. 13, pp. 2355–2363, 2012. View at Publisher · View at Google Scholar
  177. D. Bexell, S. Scheding, and J. Bengzon, “Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors,” Molecular Therapy, vol. 18, no. 6, pp. 1067–1075, 2010. View at Publisher · View at Google Scholar · View at Scopus
  178. Y. L. Hu, Y. H. Fu, Y. Tabata, and J. Q. Gao, “Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy,” Journal of Controlled Release, vol. 147, no. 2, pp. 154–162, 2010. View at Publisher · View at Google Scholar · View at Scopus
  179. S. A. Choi, S. K. Hwang, K. C. Wang et al., “Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma,” Neuro-Oncology, vol. 13, no. 1, pp. 61–69, 2011. View at Publisher · View at Google Scholar · View at Scopus
  180. M. R. Loebinger, A. Eddaoudi, D. Davies, and S. M. Janes, “Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer,” Cancer Research, vol. 69, no. 10, pp. 4134–4142, 2009. View at Publisher · View at Google Scholar · View at Scopus
  181. L. S. Sasportas, R. Kasmieh, H. Wakimoto et al., “Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 12, pp. 4822–4827, 2009. View at Publisher · View at Google Scholar · View at Scopus
  182. M. Studeny, F. C. Marini, R. E. Champlin, C. Zompetta, I. J. Fidler, and M. Andreeff, “Bone marrow-derived mesenchymal stem cells as vehicles for interferon-β delivery into tumors,” Cancer Research, vol. 62, no. 13, pp. 3603–3608, 2002. View at Google Scholar · View at Scopus
  183. H. Xin, M. Kanehira, H. Mizuguchi et al., “Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells,” Stem Cells, vol. 25, no. 7, pp. 1618–1626, 2007. View at Publisher · View at Google Scholar · View at Scopus